Provided by Tiger Trade Technology Pte. Ltd.

Tempus AI

81.90
-0.6800-0.82%
Post-market: 81.900.00000.00%19:59 EDT
Volume:4.58M
Turnover:382.55M
Market Cap:14.87B
PE:-57.13
High:86.25
Open:83.00
Low:81.68
Close:82.58
52wk High:104.32
52wk Low:40.77
Shares:181.56M
Float Shares:115.00M
Volume Ratio:0.61
T/O Rate:3.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4337
EPS(LYR):-1.4100
ROE:-67.44%
ROA:-8.55%
PB:33.42
PE(LYR):-58.09

Loading ...

The $2.6 Trillion AI Shopping Shift: Who Wins When AI Decides What You Buy?

AI Industry Frontlines
·
Yesterday

FTC Drafts Subpoena-Like Demands To Compel Testimony From Anthropic, OpenAI And Other AI Labs

AI Industry Frontlines
·
7 mins ago

OpenAI's One-Day Triple Play: Dots Goes Live, Revenue Run-Rate Nears $70 Billion, And A $1.4 Trillion Valuation Is In Talks

AI Industry Frontlines
·
Yesterday

Anthropic's IPO Filing Shows 47% Of Sales Running Through Amazon And Google — Investors, Suppliers And Rivals

AI Industry Frontlines
·
Yesterday

Who Pays For AI's Spending? Anthropic's IPO Filing Lays Bare A $4.2 Trillion Gap

AI Industry Frontlines
·
Yesterday

AI’S New Arms Race: Anthropic’S SpaceX Deal Could Reach $84.5 Billion

AI Industry Frontlines
·
Yesterday

Trump Orders Federal Agencies Onto A Single AI Portal Within 90 Days, Consolidating 29,000 Government Websites

AI Industry Frontlines
·
Yesterday

Tempus AI Diagnostics CEO Thomas Edward Schoenherr Disposes of $873,885 in Common Shares

Reuters
·
Yesterday

Tempus AI Wins FDA Clearance for ECG-MR Tool to Flag Undiagnosed Mitral Regurgitation

Reuters
·
Sep 28

Tempus Receives FDA Clearance for Its Ecg-Mr AI Product Designed to Identify Undiagnosed Mitral Regurgitation

THOMSON REUTERS
·
Sep 28

A $10–12 Trillion Bubble With All Four Fuses Lit? The Chanos–Marcus Case Against AI

Analyst Calls
·
Sep 28

Tempus AI's Officer Eric Lefkofsky sold 726,406 shares

Filings Track
·
Sep 25

Tempus AI CEO and Chairman Eric P. Lefkofsky Disposes of $17,868,777.62 in Class a Shares

Reuters
·
Sep 25

Tempus AI Inc Stock (TEM) Closed Up by 7.38% on Sep 24: What Investors Need To Know

TradingKey
·
Sep 25

tempus AI Inc Class A call volume above normal and directionally bullish

TIPRANKS
·
Sep 25

Movement Alert|Tempus AI Rises 5.07% in Regular Trading, Boosted by Extended Recursion Data License and RNA Model Authorization

Market Focus
·
Sep 24

Morgan Stanley: Semiconductors To Reach $1.5T In 2030, AI Semis ~50% Of The Pie

Analyst Calls
·
Sep 24

Form 144 | Tempus AI's Officer and Director Eric Lefkofsky proposes to sell 250,000 Shares, with a total value of approximately $19.51 Million.

Filings Track
·
Sep 23

Analysts Have Conflicting Sentiments on These Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Avantor (AVTR)

TIPRANKS
·
Sep 22

Recursion Licenses TxFM RNA Foundation Model to Tempus AI for Oncology Use in USD 12 Million Deal

Reuters
·
Sep 22